The ACRF is once again inviting world-class research teams and collaborations to apply for between $1.5 and $5 million in ACRF research funding.
Every year we provide major grants to help cutting-edge cancer research institutes develop state-of-the-art facilities, and purchase advanced technologies and equipment that speed up cancer discoveries.
No other private research funding body in Australia provides grants as large as these; and these grants help to fund research in Australia that has the power to make significant breakthroughs in cancer diagnosis and treatment.
Some of the biggest research outcomes made possible through ACRF funding include the cervical cancer vaccine, co-developed by Professor Ian Frazer AC, as well as the dedicated genetic research laboratory housed within the newly opened Kinghorn Cancer Centre in Sydney.
All applications for grants are considered and assessed by the world-class standards of the ACRF’s Medical Research Advisory Committee (MRAC), a group of highly distinguished cancer scientists. The MRAC’s recommendations for funding are then reviewed and finalised by the Foundation’s Board of Trustees.
The grant round will close on Friday, 10 May. From there applicants will be shortlisted for further assessment in the following month.